Tuesday, SafeStitch Medical Inc. (SFES.OB) received clearance from the U.S. Food and Drug Administration or FDA to market its AMID Stapler in the U.S. with the intended use in general surgery procedures for fixation of mesh, in the repair of hernia defects and in other surgical specialties for the approximation of tissues, including skin. The AMID Stapler is the first surgical stapler designed specifically for use in inguinal hernia repairs using the Lichtenstein method, in which mesh is implanted to reinforce the groin floor.
The company has also applied for clearance to market the AMID Stapler in the European Economic Community and other areas outside of the U.S. SafeStitch designed the stapler in collaboration with Parviz Amid, an early pioneer and world-renowned teacher of the Lichtenstein repair.
Safestitch Medical Inc., a developmental stage medical device company, focuses on the development and sale of medical devices. The company offers medical devices that manipulate tissues for obesity, gastroesophageal reflux disease, Barrett's esophagus, esophageal obstructions, upper gastrointestinal bleeding, hernia formation, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.